Bysanti TITRATION PACK C
RxNorm 2746023

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2746023 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Bysanti TITRATION PACK C.

The following semantic concepts and normalized strings are associated with this clinical entity:

PSN
Bysanti TITRATION PACK C
AUI:13061411
View
SY
Bysanti Titration Pack C
AUI:13061410
View
BPCK
{4 (milsaperidone 1 mg Oral Tablet [Bysanti]) / 2 (milsaperidone 2 mg Oral Tablet [Bysanti]) / 2 (milsaperidone 6 mg Oral Tablet [Bysanti]) } Pack [Bysanti Titration Pack C]
AUI:13061409
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

PSNPrescribable

Prescribable Name (PSN):
Bysanti TITRATION PACK C
(Atom ID: 13061411)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Bysanti TITRATION PACK C
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2746023
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
13061411
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
2746023
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260803F
The specific version of the vocabulary provided by the source.
Update Date
August 03, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SYPrescribable

Synonym (SY):
Bysanti Titration Pack C
(Atom ID: 13061410)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Bysanti Titration Pack C
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2746023
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
13061410
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
2746023
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260803F
The specific version of the vocabulary provided by the source.
Update Date
August 03, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
BPCKPrescribable

Brand Name Pack (BPCK):
{4 (milsaperidone 1 mg Oral Tablet [Bysanti]) / 2 (milsaperidone 2 mg Oral Tablet [Bysanti]) / 2 (milsaperidone 6 mg Oral Tablet [Bysanti]) } Pack [Bysanti Titration Pack C]
(Atom ID: 13061409)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
{4 (milsaperidone 1 MG Oral Tablet [Bysanti]) / 2 (milsaperidone 2 MG Oral Tablet [Bysanti]) / 2 (milsaperidone 6 MG Oral Tablet [Bysanti]) } Pack [Bysanti Titration Pack C]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2746023
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
13061409
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
BPCK
Brand Name Pack ({# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name])
Source Code
2746023
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260803F
The specific version of the vocabulary provided by the source.
Update Date
August 03, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN HUMAN DRUG
US
Drug available for use in Humans